[Clinical and neurophysiological effects of dual-target high-frequency rTMS over the primary motor and prefrontal cortex in Parkinson's disease].
L I AftanasIvan V BrakK I KulikovaElena FilimonovaS S DzemidovichMikhail Aleksanrovich PiradovNatalia A SuponevaA G PoidashevaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
The dual-target high-frequency rTMS over the primary motor cortex (bilateral) and the left dorsolateral prefrontal cortex has positive therapeutic effects on the motor and affective symptoms of Parkinson's disease, which are significantly stronger than that of the placebo stimulation.